VASORX

vasorx-logo

VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading the translation of technologies discovered at Massachusetts Institute of Technology (M.I.T) and Yale for the delivery of RNAs for the treatment of diseases. With the world’s first approved RNAi therapeutic, the field of RNA medicines is rapidly expanding. VasoRx utilizes novel nanoparticles that are dramatically expanding the opportunities for developing RNA therapies for diseases of the cardiovascular system as well as oncology. system & oncology such as atherosclerosis and pulmonary hypertension.

#SimilarOrganizations #People #Financial #Website #More

VASORX

Social Links:

Industry:
Biotechnology Oncology Pharmaceutical

Founded:
2018-01-01

Address:
Santa Barbara, California, United States

Country:
United States

Website Url:
http://www.vasrx.com

Total Employee:
1+

Status:
Active

Contact:
(619) 889-5199

Total Funding:
7.15 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API Content Delivery Network LetsEncrypt SSL By Default HSTS Microsoft Exchange Online Office 365 Mail


Similar Organizations

epivario-logo

EpiVario

EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

iroko-pharmaceuticals-logo

Iroko Pharmaceuticals

Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.

longevity-biotech-logo

Longevity Biotech

Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

vintabio-logo

VintaBio

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.

Current Employees Featured

michael-simons_image

Michael Simons
Michael Simons Co-Founder & Chairman of Scientific Advisory Board @ VasoRx
Co-Founder & Chairman of Scientific Advisory Board

not_available_image

Daniel Anderson
Daniel Anderson Co-Founder & Member of Scientific Advisory Board @ VasoRx
Co-Founder & Member of Scientific Advisory Board

not_available_image

Robert Langer
Robert Langer Co-Founder & Member of Scientific Advisory Board @ VasoRx
Co-Founder & Member of Scientific Advisory Board

krisztina-zsebo_image

Krisztina Zsebo
Krisztina Zsebo Co-Founder, Chief Executive Officer, and President @ VasoRx
Co-Founder, Chief Executive Officer, and President
2018-03-01

Founder


not_available_image

Daniel Anderson

krisztina-zsebo_image

Krisztina Zsebo

michael-simons_image

Michael Simons

not_available_image

Robert Langer

Investors List

good-ventures_image

Good Ventures

Good Ventures investment in Grant - VasoRx

Official Site Inspections

http://www.vasrx.com

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "VasoRx"

VasoRX

6 years of R&D to establish a cutting edge therapeutic for modern RNAi medicine. 2014 . Ground breaking discovery and publication in Nature by the pioneers of RNAi/LNP technology, profs …See details»

Team 1 — VasoRX - vasrx.com

Prof. Dan Anderson. Member of the Scientific Advisory Board, Founder of VasoRx. Daniel G. Anderson is a Professor in the Department of Chemical Engineering, the Institute for Medical Engineering and Science, the Koch …See details»

VasoRx - Crunchbase Company Profile & Funding

VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading the translation of technologies discovered at Massachusetts Institute of Technology (M.I.T) and …See details»

About 1 — VasoRX - vasrx.com

Through our first-in-class nanoparticle therapeutics, we aim to restore vascular function, reduce maladaptation, chronic inflammation and and scar formation in cardiovascular disease, like …See details»

VASORX, INC. Company Profile | San Diego, CA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for VASORX, INC. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

VasoRx, Inc. | LinkedIn

Www.vasrx.com External link for VasoRx, Inc. Industry Biotechnology Research Company size 2-10 employees Type Privately Held Employees at VasoRx, Inc. ...See details»

VasoRx 2025 Company Profile: Valuation, Funding & Investors

VasoRx General Information Description. Developer of RNA (Ribonucleic acid) therapies for diseases of the cardiovascular system as well as oncology. The company utilizes novel …See details»

VasoRx Company Profile - Office Locations, Competitors, Revenue …

VasoRx is a pharmaceutical company developing RNA therapies for diseases of the cardiovascular system as well as oncology. Its nanoparticles are made of low molecular weight …See details»

VasoRX Company Profile | Management and Employees List

Www.vasrx.com . VasoRX Profile and History. VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading the translation of technologies discovered at …See details»

Rebecque Laba - VasoRx, Inc. | LinkedIn

Executive with over 20 years experience in cross-functional, diverse leadership… · Experience: VasoRx, Inc. · Education: University of Redlands · Location: Rancho Santa Fe · 373 …See details»

Vasorx Company Profile -Sales, Contacts, Competitors – Buzzfile

Vasorx is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for approximately 6 years.See details»

Leadership - VasoRX

Dr. Tracy is a specialty biopharmaceutical consultant specialized in product development plans (with a CMC-focus) for novel nucleic acid medicines including siRNA, mRNA, and DNA, …See details»

VasoRx, Inc.:Company Profile & Technical Research,Competitor …

VasoRx is a company that provides RNA, Medicine and more. VasoRx is headquartered in United States California. VasoRx was founded in 2018.See details»

VasoRx, Inc. - VentureRadar

Similar Companies: ADARx Pharmaceuticals USA Privately Held ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and …See details»

Vasorx - Overview, News & Similar companies | ZoomInfo.com

Vasorx contact info: Phone number: (619) 889-5199 Website: www.vasrx.com What does Vasorx do? VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading …See details»

VasoRx, Inc. - BIO International Convention 2025

First-in-class proprietary nanoparticle RNAi agents for vascular diseases, including pulmonary hypertension, atherosclerosis, myocardial infarction, transplant atherosclerosis, and more; …See details»

Founders and Advisory Board - VasoRX

Skip to Content Home VasoRX TechnologySee details»

VasoRx | CipherBio

Explore VasoRx's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Possible New Era in Pain Management: FDA Approves Novel Non …

3 days ago The Institute for Clinical and Economic Review, a nonprofit organization that evaluates prescription drug cost-effectiveness, has suggested that the drug could be only …See details»

Technology - VasoRX

In 2014, the ground breaking discovery of vascular specific LNPs was published in Nature by the pioneers of RNAi/LNP technology, profs Robert Langer and Dan Anderson from MIT. Their …See details»

linkstock.net © 2022. All rights reserved